Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 19, 2023, titled "Strides Puducherry facility receives Establishment Inspection Report (EIR) from USFDA confirming the reclassification of the site from Official Action Indicated (OAI) to Voluntary Action Indicated (VAI)".